Prevalence of depression among tuberculosis patients MA Sulehri, IA Dogar, H Sohail, Z Mehdi, M Azam, O Niaz, MS Javed, ... Annals of Punjab Medical College 4 (2), 133-137, 2010 | 77 | 2010 |
Review of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer M Sun, MO Niaz, A Nelson, M Skafida, MJ Niaz Cureus 12 (6), 2020 | 51 | 2020 |
Prostate-specific membrane antigen based antibody-drug conjugates for metastatic castration-resistance prostate cancer MO Niaz, M Sun, MK Ramirez-Fort, MJ Niaz Cureus 12 (2), 2020 | 25 | 2020 |
Prostate-specific membrane antigen (PSMA)-targeted radionuclide therapies for prostate cancer M Sun, MJ Niaz, MO Niaz, ST Tagawa Current oncology reports 23, 1-11, 2021 | 23 | 2021 |
Review of commonly used prostate specific PET tracers used in prostate cancer imaging in current clinical practice MJ Niaz, M Sun, M Skafida, MO Niaz, J Ivanidze, JR Osborne, E O'Dwyer Clinical Imaging 79, 278-288, 2021 | 21 | 2021 |
Review of lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for the treatment of metastatic castration-resistant prostate cancer MO Niaz, M Sun, MK Ramirez-Fort, MJ Niaz Cureus 12 (2), 2020 | 21 | 2020 |
Dermatofibrosarcoma protuberans: The current state of multidisciplinary management MK Ramirez-Fort, B Meier-Schiesser, MJ Niaz, MO Niaz, A Feily, M Fort, ... Skinmed 18 (5), 288-293, 2020 | 14 | 2020 |
Abstract CT143: Results of combined targeting of prostate-specific membrane antigen (PSMA) with alpha-radiolabeled antibody 225Ac-J591 and beta-radiolabeled ligand 177Lu-PSMA I … ST Tagawa, E Fung, MO Niaz, M Bissassar, S Singh, A Patel, A Tan, ... Cancer Research 82 (12_Supplement), CT143-CT143, 2022 | 4 | 2022 |
Risk factor analysis between newly screened and established hepatitis C in GI and hepatology clinics N Hossain, B Puchakayala, P Kanwar, S Verma, G Abraham, Z Ivanov, ... Digestive Diseases and Sciences 62, 3193-3199, 2017 | 3 | 2017 |
Prostate-Specific Membrane Antigen Based Imaging Using 89Zr-Labeled Monoclonal Antibody (J591) NMJ Sun M, Niaz MO, Skafida M, Nelson A American Journal of Biomedical science and Research 9 (5), 391-393, 2020 | 2* | 2020 |
Quantitative assessment of PSMA imaging before and after 177Lu-PSMA-617 treatment in a Ph I/II trial. Journal of Clinical Oncology 40 (6), 37, 2022 | 1 | 2022 |
MP51-17 DEMOGRAPHICS AND SOCIOECONOMIC DESCRIPTION OF PATIENTS WITH PROSTATE CANCER IN WHOM A PROSTATE-SPECIFIC MEMBRANE ANTIGEN PET WAS PERFORMED: A SINGLE-INSTITUTION … J Martinez, K Subramanian, M Niaz, T Getz, A Patel, J Osborne, S Tagawa The Journal of Urology 207 (Supplement 5), e883, 2022 | | 2022 |
Koebner Phenomenon: Café-au-Lait Spots Developing after a Secondary-Degree Burn in a Patient with Neurofibromatosis Type 1. A Feily, MJ Niaz, M Fort, M Morales-Cruz, MO Niaz, CS Lange, ... Skinmed 20 (1), 72-74, 2022 | | 2022 |
Assessment of patient-reported outcomes (PROs) and longer-term adverse events (AEs) in phase I study of 225Ac-J591-PSMA for metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology 40 (6), 77, 2022 | | 2022 |
Ten-year follow-up of pentostatin combined with cyclophosphamide, and rituximab in previously untreated indolent B-cell lymphoma. T Khashab, MO Niaz, FB Hagemeister, JE Romaguera, MA Fanale, B Pro, ... Journal of Clinical Oncology 35 (15_suppl), e19040-e19040, 2017 | | 2017 |
Hepatitis C: An Additional Risk Factor for Poor Bowel Preparation—A Prospective Study: 1368 S Verma, B Puchakayala, N Hossain, M Niaz, Z Ivanov, O Ajah, ... Official journal of the American College of Gastroenterology| ACG 110, S591, 2015 | | 2015 |